Vote!

ADUSAVE (loxapine) Inhalation Powder Approved For Schizophrenia Or Bipolar Agitation

ADASUVE (loxapine) Inhalation Powder has just been approved by the U.S. Food and Drug Administration (FDA) for the acute treatment of agitation resulting from schizophrenia or bipolar I disorder. They anticipate that the treatment will be available around the third quarter of 2013......

read more...

Published By: Bipolar - Medical News Today - 2 days ago

• Older News
• Adasuve Approved for Agitation Associated with Schizophrenia or Bipolar I ... - Monthly Prescribing Reference Google News (3 days ago) - Alexza Pharmaceuticals announced that the FDA has approved Adasuve (loxapine inhalation powder) for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults. Adasuve is an...
  • ADUSAVE (loxapine) Inhalation Powder Approved For Schizophrenia Or Bipolar Agitation